ARCHIVES

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Lists Initiatives, Web Links For Info, About Research On Prostate Cancer

December 11, 1998

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000